Henry Rodriguez

Henry Rodriguez, MD

Professor of Pediatrics, Clinical Director of the USF Diabetes Center, Morsani College of Medicine

Professor, Health Informatics Institute

Contact Info 12901 Bruce B. Downs Blvd. MDC 62
Tampa FL 33612

Academic Email: hrodrig1@health.usf.edu

Academic Phone:(813) 396-2580

View My C.V.


  • MD, Medicine, Albany Medical College, 1987

Interdisciplinary and Emerging Signature Programs

  • Other

Research Interests

  • Studies in the development, management, and prevention of diabetes.

Recent Publications

  • Kuehl MN, Rodriguez H, Burkhardt BR, Alman AC. Tumor Necrosis Factor-α, Matrix-Metalloproteinases 8 and 9 Levels in the Saliva Are Associated with Increased Hemoglobin A1c in Type 1 Diabetes Subjects. PloS one. 10(4) : e0125320, 2015. http://www.ncbi.nlm.nih.gov/pubmed/25915398
  • Chase HP, Boulware D, Rodriguez H, Donaldson D, Chritton S, Rafkin-Mervis L, Krischer J, Skyler JS, Clare-Salzler M. Effect of docosahexaenoic acid supplementation on inflammatory cytokine levels in infants at high genetic risk for type 1 diabetes. Pediatric diabetes. , 2014. http://www.ncbi.nlm.nih.gov/pubmed/25039804
  • Pescovitz MD, Greenbaum CJ, Bundy B, Becker DJ, Gitelman SE, Goland R, Gottlieb PA, Marks JB, Moran A, Raskin P, Rodriguez H, Schatz DA, Wherrett DK, Wilson DM, Krischer JP, Skyler JS. B-lymphocyte depletion with rituximab and β-cell function: two-year results. Diabetes care. 37(2) : 453-9, 2014. http://www.ncbi.nlm.nih.gov/pubmed/24026563
  • McCarlie VW, Hartsfield JK, Blum JS, González-Cabezas C, Chin JR, Eckert GJ, Morford LA, Pescovitz MD, Rodriguez H, Fontana M, Gregory RL. Total IgA and IgA reactivity to antigen I/II epitopes in HLA-DRB1*04 positive subjects. Open journal of immunology. 3(3) , 2013. http://www.ncbi.nlm.nih.gov/pubmed/24386612
  • Pescovitz MD Greenbaum CJ Bundy B Becker DJ Gitelman SE Goland R Gottlieb PA Marks JB Moran A Raskin P Rodriguez H Schatz DA Wherrett DK Wilson DM Krischer JP Skyler JS; Type I Diabetes TrialNet Anti-CD20 Study Group. B-Iymphocyte depletion with rituximab and P-cell function: two-year results. Diabetes Care.. 37(2) : 453-9, 2013.
  • Seaquist ER, Anderson J, Childs B, Cryer P, Dagogo-Jack S, Fish L, Heller SR, Rodriguez H, Rosenzweig J, Vigersky R. Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society. Diabetes care. 36(5) : 1384-95, 2013. http://www.ncbi.nlm.nih.gov/pubmed/23589542
  • Miller KM, Beck RW, Bergenstal RM, Goland RS, Haller MJ, McGill JB, Rodriguez H, Simmons JH, Hirsch IB. Evidence of a strong association between frequency of self-monitoring of blood glucose and hemoglobin A1c levels in T1D exchange clinic registry participants. Diabetes care. 36(7) : 2009-14, 2013. http://www.ncbi.nlm.nih.gov/pubmed/23378621
  • Bergenstal RM, Ahmann AJ, Bailey T, Beck RW, Bissen J, Buckingham B, Deeb L, Dolin RH, Garg SK, Goland R, Hirsch IB, Klonoff DC, Kruger DF, Matfin G, Mazze RS, Olson BA, Parkin C, Peters A, Powers MA, Rodriguez H, Southerland P, Strock ES, Tamborlane W, Wesley DM. Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the ambulatory glucose profile. Journal of diabetes science and technology. 7(2) : 562-78, 2013. http://www.ncbi.nlm.nih.gov/pubmed/23567014
  • Rodriguez H. New technologies and old challenges in type 1 diabetes. Diabetes technology & therapeutics. 14(12) : 1082-3, 2012. http://www.ncbi.nlm.nih.gov/pubmed/23216337
  • Kaiserman K, Rodriguez H, Stephenson A, Wolka L, Fahrbach JL. Continuous subcutaneous infusion of insulin lispro in children and adolescents with type 1 diabetes mellitus. Endocrine Practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. 18(3) : 418-24, 2012. http://www.ncbi.nlm.nih.gov/pubmed/22297055
  • Vehik K, Cuthbertson D, Boulware D, Beam CA, Rodriguez H, Legault L, Hyytinen M, Rewers MJ, Schatz DA, Krischer JP. Performance of HbA1c as an early diagnostic indicator of type 1 diabetes in children and youth. Diabetes care. 35(9) : 1821-5, 2012. http://www.ncbi.nlm.nih.gov/pubmed/22699293
  • Bollepalli, S, Smith, L., Vasquez, A, Rodriguez, H, Vehik, K. Addressing the burdens of Type 1 Diabetes in Youth Clinical Practice. 9(4) : 409-24, 2012.
  • Beck RW, Tamborlane WV, Bergenstal RM, Miller KM, DuBose SN, Hall CA. The T1D Exchange clinic registry. The Journal of clinical endocrinology and metabolism. 97(12) : 4383-9, 2012. http://www.ncbi.nlm.nih.gov/pubmed/22996145
  • Peters A, Laffel L. Diabetes care for emerging adults: recommendations for transition from pediatric to adult diabetes care systems: a position statement of the American Diabetes Association, with representation by the American College of Osteopathic Family Physicians, the American Academy of Pediatrics, the American Association of Clinical Endocrinologists, the American Osteopathic Association, the Centers for Disease Control and Prevention, Children with Diabetes, The Endocrine Society, the International Society for Pediatric and Adolescent Diabetes, Juvenile Diabetes Research Foundation International, the National Diabetes Education Program, and the Pediatric Endocrine Society (formerly Lawson Wilkins Pediatric Endocrine Society). Diabetes care. 34(11) : 2477-85, 2011. http://www.ncbi.nlm.nih.gov/pubmed/22025785
  • Orban T, Bundy B, Becker DJ, DiMeglio LA, Gitelman SE, Goland R, Gottlieb PA, Greenbaum CJ, Marks JB, Monzavi R, Moran A, Raskin P, Rodriguez H, Russell WE, Schatz D, Wherrett D, Wilson DM, Krischer JP, Skyler JS. Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial. Lancet (London, England). 378(9789) : 412-9, 2011. http://www.ncbi.nlm.nih.gov/pubmed/21719096
  • Wherrett DK, Bundy B, Becker DJ, DiMeglio LA, Gitelman SE, Goland R, Gottlieb PA, Greenbaum CJ, Herold KC, Marks JB, Monzavi R, Moran A, Orban T, Palmer JP, Raskin P, Rodriguez H, Schatz D, Wilson DM, Krischer JP, Skyler JS. Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial. Lancet (London, England). 378(9788) : 319-27, 2011. http://www.ncbi.nlm.nih.gov/pubmed/21714999
  • Gottlieb PA Quinlan S Krause-Steinrauf H Greenbaum CJ Wilson DM Rodriguez H Schatz DA Moran AM Lachin JM Skyler JS and the TrialNet MMF/DZB Study Group. Failure to Preserve Beta-Cell Function with Mycophenolate Mofetil and Daclizumab Combined Therapy in Patients with New Onset Type 1 Diabetes. Diabetes Care. 33: 826-832, 2010.